Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues

These results indicate that unused residues of IPI in their original vials can be safely kept up to 28 d, following good manufacturing procedures, allowing re-use for another patient or in case of cold-chain rupture.